Current Report Filing (8-k)
April 10 2018 - 2:24PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): April 09, 2018
IMMUDYNE, INC.
(Exact name of registrant as specified
in its charter)
Delaware
|
|
333-184487
|
|
76-0238453
|
(State or other Jurisdiction
of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
1460 Broadway
New York, NY
|
|
10036
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including
area code:
866-351-5907
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☒
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.03 Amendments to Articles of
Incorporation or Bylaws; Change in Fiscal Year.
On April 9, 2018, the Board of Directors
of Immudyne, Inc. (the “Company”) adopted new by-laws (the “By-laws”), effective immediately to replace
the Company’s former by-laws in its entirety. The reasons for the adoption of the By-laws can primarily be attributed to
better align with Delaware General Corporation Law and clarify the Company’s quorum requirements at shareholder meetings.
The foregoing description of the By-laws
does not purport to be complete and is qualified in its entirety by reference to the full text of the By-laws, filed as Exhibit
3.1 to this Report and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
IMMUDYNE INC.
|
|
(Registrant)
|
|
|
Date: April 10, 2018
|
By:
|
/s/ Justin Schreiber
|
|
Name:
|
Justin Schreiber
|
|
Title:
|
Chief Executive Officer
|
2